ACAAI 2018 Allied Health Professionals Course

November 17, 2018 to November 18, 2018

Practice Excellence

Education. Patient Care. Leadership.

Target Audience

  • All practicing allergists/immunologists
  • Fellows in allergy/immunology training programs
  • Primary care physicians who care for allergy patients
  • Allied health professionals in the field of allergy and immunology 

Learning Objectives

At the conclusion of this activity, participants should be able to:

  • Identify major advances in key areas of cutting edge research in immunologic mechanisms and allergic responses, including anaphylaxis and pathophysiology of the upper airways, lungs, eyes, skin and gastrointestinal tract
  • Demonstrate knowledge of basic processes linking molecular and cellular biology and genetics with allergic pathophysiology and immunodeficiency
  • Translate emerging clinical science principles to clinical practice in patients with allergic and immunologic diseases
  • Evaluate and implement state-of-the-art diagnostic and therapeutic strategies for treating patients with allergic and immunologic diseases
  • Explain the impact of environmental exposures and external influences on patients with allergic disorders
  • Recognize emerging trends in the prevalence of allergic and immunologic disorders and discuss their impact on public health
  • Evaluate the impact of new diagnostic and therapeutic strategies on health care costs and outcomes
  • Discuss processes, tools and technologies for the efficient allergy and immunology practice
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

All identified conflicts of interest have been resolved.

Cem Akin, MD, PhD
Consultant/Advisor: Blueprint Medicines, Novartis,
Patara Pharma; Supported/Contracted Research: Dyax		Thomas B. Casale, MD, FACAAI
Consultant/Advisor: AstraZeneca, Genentech, Novartis,
Sanofi, Teva
Craig A. Alter, MD
Consultant/Advisor: Pfizer		Bradley E. Chipps, MD, FACAAI
Consultant/Advisor: AstraZeneca, Boehringer
Ingelheim, Genentech, Merck, Novartis; Speaker:
AstraZeneca, Boehringer Ingelheim, Genentech,
Merck, Novartis; Supported/Contracted Research:
Stallergenes
Leonard B. Bacharier, MD, FACAAI
Consultant/Advisor: Boehringer Ingelheim, DBV
Technologies, GlaxoSmithKline, Meda,Teva; Speaker:
AstraZeneca, Novartis		Ray S. Davis, MD, FACAAI
Consultant/Advisor: Alcon, AstraZeneca, Baxter, Meda,
Merck, Teva
Mark M. Ballow, MD, FACAAI
Consultant/Advisor: CSL Behring, Kedrion; Supported/
Contracted Research: CSL Behring; Speaker: Baxter		§ Chitra Dinakar, MD, FACAAI
Consultant/Advisor: Aerocrine; Supported/Contracted
Research: GlaxoSmithKline, Merck, Teva
Gregory W. Bensch, MD, FACAAI
Consultant/Advisor: AstraZeneca, Teva; Supported/
Contracted Research: AstraZeneca, Boehringer
Ingelheim, Pearl, Teva		Mark S. Dykewicz, MD, FACAAI
Consultant/Advisor: Merck; Supported/Contracted
Research: Novartis
J. Andrew Bird, MD, FACAAI
Speaker: Nutrica; Supported/Contracted Research:
Aimmune Therapeutics, DBV Technologies		David B. Engler, MD, FACAAI
Stock: Regeneron
Mark Boguniewicz, MD, FACAAI
Consultant/Advisor: Celgene, Regeneron; Supported/
Contracted Research: Anacor		Elizabeth A. Erwin, MD
Stock: Pfizer
Larry Borish, MD, FACAAI
Consultant/Advisor: Allakos, Knopp, Novartis,
PluriStem		Stanley M. Fineman, MD, MBA, FACAAI
Speaker: AstraZeneca, Genentech, Meda, Merck,
Mylan; Supported/Contracted Research: Genentech,
Meda
John C. Browning, MD, MBA
Supported/Contracted Research: Anacor, MedImmune,
Regeneron		David M. Fleisher, MD
Consultant/Advisor: Food Allergy Research &
Education, LabCorp, National Peanut Board,
Receptors, Nestle Nutrition Institute; Supported/
Contracted Research: Monsanto Company, Nestle
Nutrition Institute
A. Wesley Burks, MD, FACAAI
Consultant/Advisor: Dynavax Technologies,
Genentech, GLG Research, Intrexon, Perrigo,
Perosphere, Regeneron, SRA International, Sanofi,
Valeant; Board Member (for profit organization)
Stallergenes		§ Luz S. Fonacier, MD, FACAAI
Speaker: Baxter; Supported/Contracted Research:
Baxter, Genentech, Merck
§ B. Gwen Carlton, DNP, APRN, FNP-BC
Speaker: Genentech		David M. Lang, MD, FACAAI
Consultant/Advisor: Genentech, GlaxoSmithKline,
Meda, Merck; Speaker: Genentech; Supported/
Contracted Research: Genentech, Merck
Lene Heise Garvey, MD, PhD
Consultant/Advisor: Merck; Speaker: Thermo Fisher
Scientific		Bob Lanier, MD, FACAAI
Supported/Contracted Research: Merck, Novartis,
Teva; Speaker: Genentech, Merck
Maureen George, PhD, RN, AE-C
Consultant/Advisor: Teva; Speaker: Teva		§ Phillip L. Lieberman, MD, FACAAI
Consultant/Advisor: Genentech, Mylan, Teva, Valeant;
Speaker: Meda
§ Richard G. Gower, MD, FACAAI
Consultant/Advisor: CSL Behring, Dyax, Mylan, Shire,
Teva; Medical Director: HollisterStier; Speaker: CSL
Behring, Mylan, Shire, Teva; Supported/Contracted
Research: Anacor, Biocryst, Circassia, CSL Behring,
Dyax, Genentech, GlaxoSmithKline, Kedrion, Mylan,
Optinose, Pearl, Regeneron, Shire, Teva; Stock: Merck		Peter A. Lio, MD
Consultant/Advisor: Anacor, Galderma, Johnson &
Johnson, Pierre Fabre, Valeant
David F. Graft, MD, FACAAI
Consultant/Advisor: Aerocrine; Speaker: Merck		William R. Lumry, MD, FACAAI
Consultant/Advisor: Biocryst, CSL Behring, Dyax, Shire;
Speaker: CSL Behring, Dyax, Shire, Teva; Supported/
Contracted Research: ADMA Biologics, Biocryst,
Circassia, CSL Behring, Dyax, Kedrion, Mylan, Novartis,
Roche, Shire, Teva
Mitchell H. Grayson, MD, FACAAI
Supported/Contracted Research: Polyphor		§ Todd A. Mahr, MD, FACAAI
Speaker: Aerocrine, Genentech, GlaxoSmithKline,
Meda, Merck, Mylan, Sanofi, Teva
§ Matthew Greenhawt, MD, MBA, MSc, FACAAI
Consultant/Advisor: National Peanut Board;
Supported/Contracted Research: National Center for
Translational Sciences		Michael E. Manning, MD, FACAAI
Consultant/Advisor: Dyax, Shire; Speaker: Baxter, CSL
Behring, Dyax, Genentech, Merck, Shire; Supported/
Contracted Research: Amgen, AstraZeneca, Biocryst,
Dyax, Genentech, Janssen, Johnson & Johnson,
Merck, Novartis, Sanofi, Shire, Teva
Gary N. Gross, MD, FACAAI
Supported/Contracted Amgen, Genentech, Janssen,
Mylan, Perrigo, Sanofi, Teva; Speaker: Merck, Teva		Kelly M. Maples, MD, FACAAI
Speaker: Teva
Ruchi Gupta, MD, MPH
Speaker: Mylan Specialty; Supported/Contracted
Research: Food Allergy Research & Education, Mylan		Gailen D. Marshall, MD, PhD, FACAAI
Supported/Contracted Research: Amgen, AstraZeneca,
National Institutes of Health (NIH)
Nicola A. Hanania, MD, MS
Consultant/Advisor: AstraZeneca, Meda, Novartis,
Pfizer, Roche, Sunovion; Speaker: Genentech;
Supported/Contracted Research: Boehringer
Ingelheim, Chiesi, Genentech, GlaxoSmithKline, Mylan,
Novartis, Pfizer, Roche, Sunovion		• § Kevin P. McGrath, MD FACAAI
Speaker: Teva
Mary Lou Hayden, MSN, FNP-BC, AE-C
Consultant/Advisor: Boehringer Ingelheim, Mylan, Teva		J. Allen Meadows, MD, FACAAI
Consultant/Advisor: Pfizer; Stocks: Johnson & Johnson
Erika Jensen-Jarolim, MD
Speaker: Allergy Therapeutics, Meda, Roxall, Thermo
Fisher Scientific; Stocks: Biomedical International R&D
Vienna, AllergyCare Vienna		Eli O. Meltzer, MD, FACAAI
Consultant/Advisor: AstraZeneca, Boehringer
Ingelheim, Circassia, GlaxoSmithKline, Greer, Johnson
& Johnson, McNeill, Meda, Merck, Regeneron, Sanofi,
Sunovion, Teva, Takeda, Valeant; Speaker: Alcon,
Greer, Meda, Mylan, Sunovion, Teva, Takeda
§ Rohit K. Katial, MD, FACAAI
Consultant/Advisor: AstraZeneca, GlaxoSmithKline,
Meda, Teva; Speaker: GlaxoSmithKline, Meda		Anthony Montanaro, MD, FACAAI
Supported/Contracted Reearch: Circassia, Genentech,
GlaxoSmithKline, Merck, Teva
§ David A. Khan, MD, FACAAI
Speaker: Baxter, Genentech		Harold S. Nelson, MD, FACAAI
Consultant/Advisor: AstraZeneca, Circassia, Merck,
Pearl Therapeutics; Supported/Contracted Research:
Circassia
Lisa K. Kobrynski, MD, MPH, FACAAI
Supported/Contracted Research: Baxter; Speaker:
Baxter, CSL Behring		William S. Silvers, MD, FACAAI
Speaker: Teva
Jerald W. Koepke, MD, FACAAI
Supported/Contracted Research: Sanofi		Roland Solensky, MD
Supported/Contracted Research: AstraZeneca, Merck
Anna H. Nowak-Wegrzyn, MD, FACAAI
Consultant/Advisor: Merck, Nestle; Speaker: Sanofi;
Supported/Contracted Research: DBV Technologies,
Food Allergy Research & Education, NIH/NIAID, ITN,
Nutricia		§ Brett Stanaland, MD, FACAAI
Speaker: Alcon, Meda, Merck, Teva
Talal M. Nsouli, MD, FACAAI
Consultant/Advisor: Teva; Speaker: Perrigo, Thermo
Fisher Scientific		§ James L. Sublett, MD, FACAAI
Consultant/Advisor: Boston Scientific, Greer;
Speaker: Genentech, GlaxoSmithKline, Meda, Merck,
Sunovion, Teva; Supported/Contracted Research:
Array BioPharma, AstraZeneca, Boehringer Ingelheim,
Forest, Mylan, Sanofi: Stock: AllergyZone
§ Maeve E. O’Connor, MD, FACAAI
Consultant/Advisor: Novartis; Speaker: Aerocrine,
Baxter, Dyax, Greer, Meda, Merck, Mylan, Teva,
Thermo Fisher Scientific		§ Stephen A. Tilles, MD, FACAAI
Supported/Contracted Research: Amgen, Astellas,
AstraZeneca, Biota, Circassia, DBV Technologies,
Genentech, Merck, Mylan, Novartis, Perrigo, Teva
§ John J. Oppenheimer, MD, FACAAI
Consultant/Advisor: GlaxoSmithKline, Meda, Mylan;
Supported/Contracted Research: AstraZeneca,
MedImmune, Novartis		James M. Tracy, DO, FACAAI
Consultant/Advisor: Johnson and Johnson, Pfizer;
Stock: Johnson & Johnson
Jordan S. Orange, MD, PhD, FACAAI
Consultant/Advisor: ADMA Biologics, ASD Healthcare,
Baxter, CSL Behring, Walgreens		Carina Venter, PhD, RD
Consultant/Advisor: Mead Johnson, Nestle; Speaker:
Nutricia; Supported/Contracted Research: Thermo
Fisher Scientific
Reynold A. Panettieri, Jr., MD
Consultant/Advisor: AstraZeneca, Johnson & Johnson;
Supported/Contracted Research: Gilead, Johnson &
Johnson, Merck, Roche, Sanofi		Christine W. Wagner, MSN, RN, CPNP, AE-C
Speaker: Teva
Anju T. Peters, MD, FACAAI
Consultant/Advisor: Baxter, Greer, Meda; Speaker:
Celgene		Julie Wang, MD, FACAAI
Consultant/Advisor: JDP Therapeutics, Merck
Stephen P. Peters, MD, PhD
Consultant/Advisor: AstraZeneca, Boehringer
Ingelheim, CSL Behring, Gilead, Merck, Novartis,
Pfizer, Teva, PPD Development, Quintiles, Theron		Richard L. Wasserman, MD, PhD, FACAAI
Consutlant/Advisor: ADMA Biologics, Baxter, Bio
Products Lab, CSL Behring, Grifols, Kedrion, ProMetic,
Therapure Biopharma; Speaker: Baxter, CSL Behring;
Supported/Contracted Research: ADMA Biologics,
Baxter, Bio Products Labs, CSL Behring, Kedrion,
Merck, Perrigo, Sanofi, Teva
§ Michael Pistiner, MD, MMSc, FACAAI
Stock: AllergyHome.org		Stephen I. Wasserman, MD, FACAAI
President: ABAI; consultant(sp): Pathway Genomics
Jay M. Portnoy, MD, FACAAI
Speaker: Mylan, Thermo Fisher Scientific		Richard W. Weber, MD, FACAAI
Consultant/Advisor: Genentech; Speaker: AstraZeneca,
Meda, Merck
Marc A. Riedl, MD, MS
Consultant/Advisor: Baxter, BioCryst, CSL Behring,
Dyax, Salix, Shire: Speaker: Baxter, CSL Behring, Dyax,
Salix, Shire: Supported/Contracted Research: Amgen,
Biocryst, CSL Behring, Dyax, Shire		Bruce L. Zuraw, MD, FACAAI
Consultant/Advisor: BioCryst, CSL Behring, Dyax,
Genentech, Isis, Novartis, Sanofi, Shire
§ Deidra H. Sanders, MSN, APRN, FNP-BC
Consultant/Advisor: Meda; Stock: AllergyZone		 
§ Charles J. Siegel, MD, FACAAI
Consultant/Advisor: Meda; Speaker: Meda, Teva		 
  
• = Planner §= Moderator 


The following have no financial relationships to disclose:

Juan Adams, MDNabeel Farooqui, MD
Karla Adams, MDTracy Fausnight, MD, FACAAI
David B. Allen, MDAlessandro Fiocchi, MD, FACAAI (SC)
§ Amal H. Assa’ad, MD, FACAAI§ Michael B. Foggs, MD, FACAAI
§ Sami L. Bahna, MD, DrPH, FACAAI§ Karen A. Freedle, MD, FACAAI
Aleena Banerji, MDTheodore M. Freeman, MD, FACAAI
Charles Barnes, PhDMarianne N. Frieri, MD, PhD, FACAAI
Rachel Bean, MDPinkus Goldberg, MD, FACAAI
Avraham Beigelman, MDPaul A. Greenberger, MD, FACAAI
Joseph A. Bellanti, MD, FACAAIMagdalena Grzyb, MD
• § Cheryl K. Bernstein, BSN, RN, CCRCMalike Gupta, MD
• § David I. Bernstein, MD, FACAAIDaniel L. Hamilos, MD, FACAAI
Leonard Bielory, MD, FACAAII. Celine Hanson, MD, FACAAI
§ Theresa A. Bingemann, MD, FACAAIJill Hanson, MD
Cheryl Blackwell, BSN, RN, AE-CCurtis Hedberg, MD, FACAAI
Hannelore A. Brucker, MD, FACAAI (SC)Alice Hoyt, MD
Paula Busse, MDFred H. Hsieh, MD, FACAAI
Ronna L. Campbell, MD, PhDKuan-Hsiang G. Huang, MD, PhD
Mariana C. Castells, MD, PhD, FACAAIYvonne Huang, MD
§ Helen Hei-ling Chan, MD, FACAAIElliot Israel, MD
Mirna Chehade, MD, MPH• Charlotte M. Jacobsen, MSN, RN
Meng Chen, MDJaison Jose, DO
Robert Chiffelle, MHSARobert J. Karman, MD
Seong H. Cho, MDMichael D. Keller, MD
Melanie Chong, MD• John M. Kelso, MD, FACAAI
Christina E. Ciaccio, MD, MSc, FACAAIRebecca Koransky, MD
• Kimberly G. Clay, MN, APRN, FNP-BC• Tao T. Le, MD, MHS, FACAAI
David E. Cohen, MD§ Gerald B. Lee, MD
Kevin Cook, MDRobert F. Lemanske, MD, FACAAI
• Mark L. Corbett, MD, FACAAI• § James T. Li, MD, PhD, FACAAI
• Peter S. Creticos, MDSamantha Lin, MD
Howard C. Crisp, MDBaojuan Liu
Mark A. Davis-Lorton, MD, FACAAI• § Bryan L. Martin, DO, FACAAI
Ves Dimov, MDFernando D. Martinez, MD
Nicholas DitzlerHannia Matt, MD
• § William K. Dolen, MD, FACAAIStephanie Mawhirt, DO
Steve Dorman, MDJacek Mazurek, MD
Dumitru Moldovan, MDPeter C. Schalock, MD
• Kevin R. Murphy, MD, FACAAI (SC)William T. Shearer, MD, PhD
Kari C. Nadeau, MD, PhDMichael Sherenian, MD
Naveen Nannapaneni, MD• § Jodi Shroba, MSN, APRN, CPNP
Maya Nanda, MD, MScMili Shum, MD
Elham A. Nekoo, MDWilliam S. Silvers, MD
Michael R. Nelson, MD, PhD, FACAAIDavid P. Skoner, MD, FACAAI
Victoria NelsonRaymond S. Slavin, MD, FACAAI
• § Andrew Nickels, MD• Sheldon L. Spector, MD, FACAAI
Noreen H. Nicol, PhD, RN, FNP, NEA-BCJonathan M. Spergel, MD, PhD, FACAAI
Irum Noor, DOSarah Spriet, DO
Lois M. Nora, MD, JD, MBAWhitney Stevens, MD, PhD
Safa Nsouli, MDPatricia H. Stewart, MD
Mark T. O’Hollaren, MD, FACAAIJames W. Sublett, MD, FACAAI
Grant C. Olson, MD, FACAAIMichael S. Tankersley, MD, FACAAI
Roy A. Orden, MDJames S. Taylor, MD
Thamiris Palacios, DOMary C. Tobin, MD, FACAAI
Dipika R. Patel, MDStephen K. Tsui, PhD
Neha N. Patel, MDJanna M. Tuck, MD, FACAAI
Priya Patel, MDJoseph C. Turbyville MD, FACAAI
Sheenal Patel, MD• Kay Tyler, BS, BA, MBA
David L. Patterson, MD, MBA, MS, FACAAIPeter Vadas, MD, PhD
Tammy Peng, MD• § Dana V. Wallace, MD, FACAAI
Maureen M. Petersen, MD, FACAAIKathryn R. Wessell, DO
Thomas A. Platts-Mills, MD, FACAAIC. Ross Westley, MD, FACAAI
Brooke I. Polk, MDMartha White, MD, FACAAI
Donald W. Pulver, MD, FACAAIP. Brock Williams, PhD, FACAAI (SC)
Vijay Ramakrishnan, MDAndrew Winslow, MD
Avner Reshef, MDPriscilla Wong, MD
Lanny J. Rosenwasser, MD, FACAAIShijun Xi, MD
• John M. Routes, MD, FACAAIKenneth Yeager, PhD
Tara V. Saco, MDCherie Y. Zachary, MD, FACAAI
Steve Shah, MDMyron Zitt, MD, FACAAI
  
• = Planner §= Moderator 

























• = Planner §= Moderator

Course summary
Available credit: 
  • 7.50 AANP
  • 7.50 AMA PRA Category 1 Credit™
  • 7.50 Attendance
Course opens: 
11/12/2018
Course expires: 
11/18/2018
Event starts: 
11/17/2018 - 10:00am CST
Event ends: 
11/18/2018 - 11:30am CST
Add to calendar: 
Moscone West Convention Center
San Francisco, CA
United States

Available Credit

  • 7.50 AANP
  • 7.50 AMA PRA Category 1 Credit™
  • 7.50 Attendance
Please login or create an account to take this course.